Tissue engineering for the replacement of organ function in the genitourinary system

American Journal of Transplantation

Volumn 4, Issue SUPPL. 6, 2004, Pages 58-73

  Atala, Anthony ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; BIOMATERIAL; COLLAGEN; MITOCHONDRIAL DNA; POLYESTER;

BIODEGRADABILITY; BLADDER RECONSTRUCTION; CELL GROWTH; CONFERENCE PAPER; GENITAL SYSTEM; HUMAN; KIDNEY; MOLECULAR CLONING; NONHUMAN; PENIS PROSTHESIS; PRIORITY JOURNAL; STEM CELL; TESTIS; TISSUE ENGINEERING; TISSUE GROWTH; URETER; URETHROPLASTY; URINE INCONTINENCE; UROGENITAL SYSTEM; UROGENITAL TRACT DISEASE; UROGENITAL TRACT INJURY; UROGENITAL TRACT MALFORMATION; VESICOURETERAL REFLUX;

EID: 1442338595     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6135.2004.0346.x     Document Type: Conference Paper

References (119)

1. Carrel A, Lindbergh C. The Culture of Organs. New York; Paul B. Hoeber, Inc, 1938.
2. Atala A. Tissue engineering in the genitourinary system. In: Atala, A Mooney, D. (eds) Tissue Engineering. Boston, MA; Birkhauser Press, 1997, 149.
3. Atala A. Commentary on the replacement of urologic associated mucosa. J Urol 1995; 156: 338.
4. Atala A. Autologous cell transplantation for urologic reconstruction. J Urol 1998; 159: 2.
5. Atala A, Cima LG, Kim W et al. Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux. J Urol 1993; 150: 745.
6. Atala A, Kim W, Paige KT, Vacanti CA, Retik AB. Endoscopic treatment of vesicoureteral reflux with chondrocyte-alginate suspension. J Urol 1994; 152: 641.
7. Kershen RT, Atala A. Advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux. Urol Clin 1999: 26.
8. Atala A, Peters CA, Retik AB, Mandell J. Endoscopic treatment of vesicoureteral reflux with a self-detachable balloon system. J Urol 1992; 148: 724-728.
9. Atala A, Freeman MR, Vacanti JP, Shepard J, Retik AB. Implantation in vivo and retrieval of artificial structures consisting of rabbit and human urothelium and human bladder muscle. J Urol 1993; 150: 608-612.
10. Cilento BG, Freeman MR, Schneck FX, Retik AB, Atala A. Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro. J Urol 1994; 152: 655.
11. Yoo JJ, Atala A. A novel gene delivery system using urothelial tissue engineered neo-organs. J Urol 1997; 158: 1066-1070.
12. Machluf M, Atala A. Emerging concepts for tissue and organ transplantation. Graft 1998; 1: 31.
13. Yoo JJ, Lee I, Atala A. Cartilage rods as a potential material for penile reconstruction. J Urol 1998; 160: 1164.
14. Fauza DO, Fishman S, Mehegan K, Atala A. Videofetoscopically assisted fetal tissue engineering: skin replacement. J Ped Surg 1998; 33: 377.
15. Yoo JJ, Meng J, Oberpennin F, Atala A. Bladder augmentation using allogenic bladder submucosa seeded with cells. Urol 1998; 51: 221.
16. Fauza DO, Fishman S, Mehegan K, Atala A. Videofetoscopically assisted fetal tissue engineering: bladder augmentation. J Ped Surg 1998; 33: 7.
17. Amiel GE, Atala A. Current and future modalities for functional renal replacement. Urol Clin 1999: 26.
18. Yoo JJ, Park H, Lee I, Atala A. Autologous engineered cartilage rods for penile reconstruction. J Urol 1999; 162: 1119-1121.
19. Park HJ, Kershen R, Yoo J, Atala A. Reconstitution of human corporal smooth muscle and endothelial cells in vitro. J Urol 1999; 162: 1106-1109.
20. Oberpenning FO, Meng J, Yoo J, Atala A. De novo reconstitution of a functional urinary bladder by tissue engineering. Nature Biotech 1999; 17: 2.
21. Atala A. Future perspectives in reconstructive surgery using tissue engineering. Urol Clin 1999: 26; 157-161.
22. Scriven SD, Booth C, Thomas DF, Trejdosiewicz LK, Southgate J. Reconstitution of human urothelium from monolayer cultures. J Urol, 1997; 158(3 Part 2): 1147-1152.
23. Liebert M, Hubbel A, Chung M et al. Expression of mal is associated with urothelial differentiation in vitro identification by differential display reverse-transcriptase polymerase chain reaction. Differentiation 1997; 61(3): 177-185.
24. Puthenveettil JA, Burger MS, Reznikoff CA. Replicative senescence in human uroepithelial cells. Adv Exp Med Biol 1999; 462: 83-91.
25. Liebert M, Wedemeyer G, Abruzzo LV et al. Stimulated urothelial cells produce cytokines and express an activated cell surface antigenic phenotype. Semin Urol 1991; 9(2): 124-130.
26. Tobin MS, Freeman MR, Atala A. Maturational response of normal human urothelial cells in culture is dependent on extracellular matrix and serum additives. Surg Forum 1994; 45: 786.
27. Freeman MR, Yoo JJ, Raab G et al. Heparin-binding EGF-like growth factor is an autocrine factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. J Clin Invest 1997; 99(5): 1028.
28. Nguyen HT, Park JM, Peters CA et al. Cell-specific activation of the HB-EGF and ErbB1 genes by stretch in primary human bladder cells. In vitro Cell Dev Biol 1999; 35: 371-375.
29. Harriss DR. Smooth muscle cell culture. a new approach to the study of human detrusor physiology and pathophysiology. Br J Urol 1995; 75(Suppl. 1): 18-26.
30. Solomon LZ, Jennings AM, Sharpe P, Cooper AJ, Malone PS. Effects of short-chain fatty acids on primary urothelial cells in culture: implications for intravesical use in enterocystoplasties. J Laboratory Clin Med 1998; 132(4): 279-283.
31. Lobban ED, Smith BA, Hall GD et al. Uroplakin gene expression by normal and neoplastic human urothelium. Am J Pathol 1998; 153(6): 1957-1967.
32. Rackley RR, Bandyopadhyay SK, Fazeli-Matin S, Shin MS, Appell R. Immunoregulatory potential of urothelium: characterization of NF-kappaB signal transduction. J Urol 1999; 162(5): 1812-1816.
33. Bergsma JE, Rozema FR, Bos RRM et al. Biocompatibility and degradatin mechanism of predegraded and non-degraded poly (lactide) implants: an animal study. Mater Med 1995; 6: 715-724.
34. Kim BS, Mooney DJ. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trend Biotechnol 1998; 16: 224-230.
35. Pariente JL, Kim BS, Atala A. In vitro biocompatibility assessment of naturally-derived and sythetic biomaterials using normal human urothelial cells. J Biomed Mat Res 2001; 55: 33-39.
36. Pariente JL, Kim BS, Atala A. In vitro Biocompatibility Evaluation of Naturally Derived and Synthetic Biomaterials Using Normal Human Bladder Smooth Muscle. J Urol 2002; 167: 1867-1871.
37. Li ST. Biologic biomaterials: tissue-derived biomaterials (collagen). In: The Biomedical Engineering Handbook. Brozino JD. (ed) Boca Ranton, FL; CRS Press, 1995, 627-647.
38. Silver FH, Pins G. Cell growth on collagen: a review of tissue engineering using scaffolds containing extracellular matrix. J Long-Term Effects Med Implants 1992; 2: 67-80.
39. Sam AE, Nixon AJ. Chondrocyte-laden collagen scaffolds for resurfacing extensive articular cartilage defects. Osteoarthritis Cartilage 1995; 3: 47-59.
40. Smidsrød O, Skjåk-Bræk G. Alginate as an immobilization matrix for cells. Trend Biotechnol 1990; 8: 71-78.
41. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210: 908-910.
42. Piechota HJ, Dahms SE, Nunes LS, Dahiya R, Lue TF, Tanagho EA. In vitro functional properties of the rat bladder regenerated by the bladder acellular matrix graft. J Urol 1998; 159: 1717-1724.
43. Dahms SE, Piechota HJ, Dahiya R, Lue TF, Tanagho EA. Composition and biochemical properties of the bladder acellular matrix graft. comparative analysis in rat, pig and human. Br J Urol 1998; 82: 411-419.
44. Chen F, Yoo JJ, Atala A. Acellular collagen matrix as a possible 'off the shelf' biomaterial for urethral repair. Urol 1999; 54: 407-410.
45. Gilding DK. Biodegradable polymers. In: Biocompatibility of Clinical Implant Materials. Williams DF. (ed)) Boca Ranton, FL; CRS Press, 1981, 209-232.
46. Freed LE, Vunjak-Novakovic G, Biron RJ et al. Biodegradable polymer scaffolds for tissue engineering. Biotechnology 1994; 12: 689-693.
47. Mikos AG, Thorsen AJ, Czerwonka LA et al. Preparation and characterization of poly (1-lactic acid) foams. Polymer 1994; 35: 1068-1077.
48. Harris LD, Kim BS, Mooney DJ. Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res 1998; 42: 396-402.
49. Peppas NA, Langer R. New challenges in biomaterials. Science 1994; 263: 1715-1720.
50. Bazeed MA, Thüroff JW, Schmidt RA, Tanagho EA. New treatment for urethral strictures. Urol 1983; 21: 53-57.
51. Atala A, Vacanti JP, Peters CA, Mandell J, Retik AB, Freeman MR. Formation of urothelial structures in vitro from dissociated cells attached to biodegradable polymer scaffolds in vitro. J Urol 1992; 148: 658.
52. Olsen L, Bowald S, Busch C et al. Urethral reconstruction with a new synthetic absorbable device. Scan J Urol Nephrol 1992; 26: 323-326.
53. Kropp BP, Ludlow JK, Spicer D et al. Rabbit urethral regeneration using small intestinal submucosa onlay grafts. Urol 1998; 52(1): 138-142.
54. Sievert KD, Bakircioglu ME, Nunes L, Tu R, Dahiya R, Tanagho EA. Homologous acellular matrix graft for urethral reconstruction in the rabbit: histological and functional evaluation. J Urol 2000; 163(6): 1958-1965.
55. EI, Kassaby AW, Retik AB, Yoo JJ, Atala A. Urethral Stricture Repair with an 'Off the Shelf' Collagen Matrix. J Urol 2003; 169: 170-173.
56. DeFilippo RE, Yoo JJ, Chen F, Atala A. Urethral Replacement Using Cell-Seeded Tubularized Collagen Matrices. J Urol, 2002; 168: 1789-1793.
57. DeFilippo RE, Pohl HG, Yoo JJ, Atala A. Total Penile Urethra Replacement With Autologous Cell-Seeded Collagen Matrices. J Urol 2002; 167(Suppl.): 152-153. (Abstract).
58. Neuhof H. Fascial transplantation into visceral defects: An experimental and clinical study. Surg Gynecol Obst 1917; 25: 383.
59. Tsuji I, Ishida H, Fujieda J. Experimental cystoplasty using preserved bladder graft. J Urol 1961; 85: 42.
60. Kambic H, Kay R, Chen JF, Matsushita M, Harasaki H, Zilber S. Biodegradable pericardial implants for bladder augmentation: a 2.5-year study in dogs. J Urol 1992; 148: 539-543.
61. Kelami A, Ludtke-Handjery A, Korb G, Roll J, Schnell J, Danigel KH. Alloplastic replacement of the urinary bladder wall with lyophilized human dura. Europ Surg Res 1970; 2: 195.
62. Fishman IJ, Flores FN, Scott B, Spjut HJ, Morrow B. Use of fresh placental membranes for bladder reconstruction. J Urol 1987; 138: 1291.
63. Probst M, Dahiya R, Carrier S, Tanagho EA. Reproduction of functional smooth muscle tissue and partial bladder replacement. Br J Urol 1997; 79: 505.
64. Sutherland RS, Baskin LS, Hayward SW, Cunha GR. Regeneration of bladder urothelium, smooth muscle, blood vessels, and nerves into an acellular tussue matrix. J Urol 1996; 156: 571-577.
65. Kropp BP, Sawyer BD, Shannon HE et al. Characterization of using small intestine submucosa regenerated canine detrusor: assessment of reinnervaation, in vitro compliance and contractility. J Urol 1996; 156: 599-607.
66. Vaught JD, Kroop BP, Sawyer BD et al. Detrusor regeneration in the rat using porcine small intestine submucosal grafts: functional innervation and receptor expression. J Urol 1996; 155: 374-378.
67. Probst M, Dahiya R, Carrier S, Tanagho EA. Reproduction of functional smooth muscle tissue and partial bladder replacement. Br J Urol 1997; 79: 505-515.
68. Kropp BP, Rippy MK, Badylak SF et al. Small intestinal submucosa: urodynamic and histopahtologic evaluation in long term canine bladder augmentations. J Urol 1996; 155: 2098-2104.
69. Lai JY, Yoo JJ, Wulf T, Atala A. Bladder Augmentation Using Small Intestinal Submucosa Seeded With Cells. J Urol 2002; 167(Suppl.): 257. (Abstract).
70. Brown AL, Farhat W, Merguerian PA, Wilson GJ, Khoury AE, Woodhouse KA. 22 week assessment of bladder accellular matrix as a bladder augmentation material in a porcine model. Biomaterials, 2002 May; 23(10): 2179-2190.
71. Reddy PP, Barrieras DJ, Wilson G et al. Regeneration of functional bladder substitutes using large segment acellular matrix allografts in a porcine model. J Urol 2000; 164(3 Part 2): 936-941.
72. Merguerian PA, Reddy PP, Barrieras DJ, et al. Acellular bladder matrix allografts in the regeneration of functional bladders: evaluation of large-segment (> 24 cm) substitution in a porcine model. BJU Int 2000; 85(7): 894-898.
73. Portis AJ, Elbahnasy AM, Shalhav AL et al. Laparascopic augmentation cystoplasty with different biodegradable grafts in an animal model. J Urol 2000; 164(4): 1405-1411.
74. Portis AJ, Elbahnasy AM, Shalhav AL et al. Laparoscopic midsagittal hemicystectomy and replacement of bladder wall with small intestinal submucosa and reimplantation of ureter into graft. J Endourol 2000 March; 14(2): 203-211.
75. Gleeson MJ, Griffith DP. The use of aloplastic biomaterials in bladder substitution. J Urol 1992; 148: 1377.
76. Bona AV, De Gresti A. Partial substitution of urinary bladder with Teflon prothesis. Minerva Urol 1966; 18: 43.
77. Monsour MJ, Mohammed R, Gorham SD, French DA, Scott R. An assessment of a collagen/vicryl composite memebrane to repair defects of the urinary bladder in rabbits. Urol Res 1987; 15: 235.
78. Rohrmann D, Albrecht D, Hannappel J, Gerlach R, Schwarzkopp G, Lutzeyer W. Alloplastic replacement of the urinary bladder. J Urol 1996; 156: 2094.
79. De Boer WI, Schuller AG, Vermay M, van der Kwast TH. Expression of growth factors and receptors during specific phases in regenerating urothelium after acute injury in vitro. Am J Path 1994; 145: 1199.
80. Baker R, Kelly T, Tehan T, Putman C, Beaugard E. Subtotal cystectomy and total bladder regeneration in treatment of bladder cancer. J Am Med Ass 1955; 168: 1178.
81. Gorham SD, French DA, Shivas AA, Scott R. Some observations on the regeneration of smooth muscle in the repaired urinary bladder of the rabbit. Eur Urol 1989; 16: 440.
82. Kershen RT, Yoo JJ, Moreland RB, Krane RJ, Atala A. Novel system for the formation of human corpus cavernosum smooth muscle tissue in vitro. J Urol 1998; 159(Suppl.): 156.
83. Falke G, Yoo J, Machado M, Moreland R, Atala A. Corporal tissue for penile reconstruction. J Tissue Eng 2003.
84. Kwon TG, Yoo JJ, Atala A. Autologous Penile Corpora Cavernosa Replacement Using Tissue Engineering Techniques. J Urol 2002; 168(4): 1754-1758.
85. Nukui F, Okamoto S, Nagata M, Kurokawa J, Fukui J. Complications and reimplantation of penile implants. Int J Urol 1997; 4: 52.
86. Thomalla JV, Thompson ST, Rowland RG, Mulcahy JJ. Infectious complications of penile prosthetic implants. J Urol 1987; 138(1): 65-67.
87. Diamond DA, Caldamone AA. Endoscopic correction of vesicoureteral reflux in children using autologous chondrocytes: preliminary results. J Urol 1999; 162: 1185.
88. Bent A, Tutrone R, McLennan M, Lloyd K, Kennelly M, Badlani G. Treatment of Intrinsic Sphincter Deficiency Using Autologous Ear Chondrocytes as a Bulking Agent. Neurourol Urodynam 2001; 20: 157-165.
89. Yokoyama T, Chancellor MB, Watanabe T et al. Primary myoblasts injection into the urethra and bladder as a potential treatment of stress urinary incontinence and impaired detrusor contractility; long term survival without significant cytotoxicity. J Urol 1999; 161: 307.
90. Chancellor MB, Yokoyama T, Tirney S et al. Preliminary results of myoblast injection into the urethra and bladder wall. a possible method for the treatment of stree urinary incontinence and impaired detrusor contractility. Neurourol Urodyn 2000; 19(3): 279-287.
91. Strasser H, Marksteiner R, Eva M et al. Transurethral Ultrasound Guided Injection of Clonally Cultured Autologous Myoblasts and Fibroblasts: Experimental Results. Proceedings of the 2003 International Bladder Symposium. Ridgefield, CT; National Bladder Foundation, 2003, 6.
92. Bartsch G, Yoo J, Kim B, Atala A. Stem Cells in Tissue Engineering Applications for Incontinence. J Urol 2000; 1009S: 227.
93. Raya-Rivera A, Yoo J, Atala A. Hormone producing granulosa stem cells for intersex disorders. American Academy of Pediatrics Meeting, Chicago. 2000, 29.
94. Lanza RP et al. The ethical reasons for stem cell research. Science, 2001; 293: 1299.
95. Atala A, Lanza RP. Methods of Tissue Engineering. San Diego, CA; Academic Press, 2001.
96. Atala A, Mooney D. Synthetic Biodegradable Polymer Scaffolds. Boston, MA; Birkhaüser, 1997.
97. Lanza RP, Cibelli JB, West MD. Prospects for the use of nuclear transfer in human transplantation. Nat Biotechnol 1999; 17: 1171-1174.
98. Evans MJ et al. Mitochondrial DNA genotypes in nuclear transfer-derived cloned sheep. Nat Genet 1999; 23: 90-93.
99. Hiendleder S, Schmutz SM, Erhardt G, Green RD, Plante Y. Transmitochondrial differences and varying levels of heteroplasmy in nuclear transfer cloned cattle. Mol Reprod Dev 1999; 54: 24-31.
100. Steinborn R et al. Mitochondrial DNA heteroplasmy in cloned cattle produced by fetal and adult cell cloning. Nat Genet 2000; 25: 255-257.
101. Humes HD, Buffington DA, MacKay SM, Funke AJ, Weitzel WF. Replacement of renal function in uremic animals with a tissue-engineered kidney. Nat Biotechnol 1999; 17: 451-455.
102. Cieslinsk DA, Humes HD. Tissue engineering of a bioartificial kidney. Biotechnol Bioeng 1994; 43: 781-791.
103. MacKay SM, Kunke AJ, Buffington DA, Humes HD. Tissue engineering of a bioartificial renal tubule. ASAIO J 1998; 44: 179-183.
104. Aebischer P, Ip TK, Panol G, Galletti PM. The bioartificial kidney: progress towards an ultrafiltration device with renal epithelial cells processing. Life Support Syst 1987; 5: 159168.
105. Ip T, Aebischer P, Galletti PM. Cellular control of membrane permeability. Implications for a bioartificial renal tubule. ASAIO Trans 1988; 34: 351-355.
106. Humes HD. Renal replacement devices. In: Lanza RP Langer R, Vacanti J, (eds). Principles of Tissue Engineering, 2nd edn. San Diego; Academic Press, 2000, 645-653.
107. Amiel A, Yoo J, Atala A. Renal therapy using tissue engineered constructs and gene delivery. W J Urol 2000; 18: 71-79.
108. Lanz RP, Hayes JL, Chick WL. Encapsulated cell technology. Nat Biotech 1996; 14: 1107-1111.
109. Kuhtreiber WM, Lanza RP, Chick WL, (eds). Cell Encapsulation Technology and Therapeutics. Boston; Birkhauser, 1998.
110. Lanza RP, Chick WL, (eds). Immunoisolation of Pancreatic Islets. Austin; R.G. Landes, 1994.
111. Joki T, Machluf M, Atala A et al. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nature Bio 2001; 19: 35-39.
112. Lanza RP, Chung HY, Yoo JJ et al. Generation of histocompatible tissues using nuclear transplantation. Nat Biotech 2002; 20: 689.
113. Lanza RP, et al. Cloning of an endangered species (Bos gaurus) Using Interspecies Nuclear Transfer Cloning 2000; 2: 79-90.
114. Fischer Lindahl K, Hermel E, Loveland BE, Wang CR. Maternally transmitted antigen of mice. Ann Rev Immunol 1991; 9: 351-372.
115. Fischer Lindahl K, Hermel E, Loveland BE, Wang CR. Maternally transmitted antigen of mice. Annu Rev Immunol 1991; 9: 351-372.
116. Hadley GA, Linders B, Mohanakumar T. Immunogenicity of MHC class I alloantigens expressed on parenchymal cells in the human kidney. Transplantation 1992; 54: 537-542.
117. Yard BA et al. Analysis of T cell lines from rejecting renal allografts. Kidney Int 1993; 43: S133-S138.
118. Bailey DW. Genetics of histocompatibility in mice. I. New loci and congenic lines. Immunogenetics, 1975; 2: 249-256.
119. Mohanakumar T. The role of MHC and non-MHC antigens in allograft immunity. Austin, TX; R.G. Landes Co., 1994, 1-115.